Observational studyEndocrine2019

Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.

Luca Degli Esposti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.